Steve Miller - 25 Aug 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Operating Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
25 Aug 2021
Net transactions value
-$70,240
Form type
4
Filing time
26 Aug 2021, 16:47:03 UTC
Previous filing
17 Aug 2021
Next filing
06 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $374,400 +120,000 +17% $3.12* 821,724 25 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $444,640 -80,000 -9.7% $5.56 741,724 25 Aug 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 -120,000 -7.9% $0.000000 1,405,000 25 Aug 2021 Common Stock 120,000 $3.12 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options and tax withholding requirements.
F2 Shares were sold in various lots from $5.51 to $5.61 per share. The listed sale price represents a weighted average price for the shares sold.
F3 Options vested in three annual tranches beginning on August 28, 2015.